- Home
- SABS vs SUGP Comparison
SABS vs SUGP Comparison
Compare SABS & SUGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- SUGP
- Stock Information
- Founded
- SABS 2014
- SUGP 1998
- Country
- SABS United States
- SUGP Hong Kong
- Employees
- SABS N/A
- SUGP N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- SUGP
- Sector
- SABS Health Care
- SUGP
- Exchange
- SABS Nasdaq
- SUGP NYSE
- Market Cap
- SABS 23.9M
- SUGP 20.3M
- IPO Year
- SABS N/A
- SUGP 2024
- Fundamental
- Price
- SABS $3.10
- SUGP $1.74
- Analyst Decision
- SABS Strong Buy
- SUGP
- Analyst Count
- SABS 5
- SUGP 0
- Target Price
- SABS $12.40
- SUGP N/A
- AVG Volume (30 Days)
- SABS 78.1K
- SUGP 1.6M
- Earning Date
- SABS 11-06-2024
- SUGP 11-26-2024
- Dividend Yield
- SABS N/A
- SUGP N/A
- EPS Growth
- SABS N/A
- SUGP N/A
- EPS
- SABS N/A
- SUGP 0.10
- Revenue
- SABS $1,512,723.00
- SUGP $20,252,232.00
- Revenue This Year
- SABS N/A
- SUGP N/A
- Revenue Next Year
- SABS N/A
- SUGP N/A
- P/E Ratio
- SABS N/A
- SUGP $16.96
- Revenue Growth
- SABS N/A
- SUGP N/A
- 52 Week Low
- SABS $2.16
- SUGP $0.98
- 52 Week High
- SABS $9.72
- SUGP $5.86
- Technical
- Relative Strength Index (RSI)
- SABS 48.28
- SUGP 56.59
- Support Level
- SABS $3.17
- SUGP $1.07
- Resistance Level
- SABS $3.74
- SUGP $1.20
- Average True Range (ATR)
- SABS 0.48
- SUGP 0.27
- MACD
- SABS -0.04
- SUGP 0.09
- Stochastic Oscillator
- SABS 17.53
- SUGP 44.16
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About SUGP SU GROUP HLDGS LTD
SU Group Holdings Ltd and its subsidiaries is an integrated security-related services company. The company has two reportable segments: security-related engineering services, and security guarding and screening services and related vocational training services. The company generates the majority of its revenue from the security-related engineering services segment.